Skip to main content
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
48.17
+2.90 (6.41%)
At close: Aug 13, 2025, 4:00 PM
47.51
-0.66 (-1.37%)
Pre-market: Aug 14, 2025, 8:53 AM EDT

PTC Therapeutics Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Collaboration
1.09B 100.36M - - - 150.08M - - 50.06M 75.08M 85.06M - 55.05M 62.56M - -
Collaboration Growth
1,347.19% 17.98% - - - 172.60% - - -19.99% 3.51% 35.92% - - - - -
Net Product
576.77M 600.95M 601.31M 609.92M 651.30M 661.25M 633.70M 623.84M
Net Product Growth
-11.44% -9.12% -5.11% -2.23% 9.84% 23.55% 20.33% 22.79%
Royalty
209.15M 203.86M 196.70M 185.51M 169.18M 168.86M 157.73M 140.48M - -
Royalty Growth
23.63% 20.73% 24.71% 32.05% 34.85% 48.74% 66.14% 86.96% - -
Manufacturing
- - - 5.00M 7.06M 7.69M - - - - - - - - - - - -

Revenue by Product
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Translarna
322.70M 340.30M 321.50M 318.20M 344.30M 355.80M 336.40M 344.00M
Translarna Growth
-6.27% -4.36% -4.43% -7.50% 6.10% 23.28% 11.21% 17.37%
Emflaza
197.20M 206.70M 224.10M 239.60M 258.00M 255.10M 245.80M 233.20M
Emflaza Growth
-23.57% -18.97% -8.83% 2.74% 15.02% 16.86% 18.34% 16.60%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.